Institutional Knowledge Map (KMap)
Map
Services
How To Use
About
Toggle theme
Loading...
Menu
Niyuri Fleming
Manager, Clinical Research
Cancer Center Division
Map Page
Research Area
cancer immunotherapy,
metastatic breast cancer,
immunotherapy combinations,
hormone therapy resistance,
oncology,
clinical trial,
chemotherapy,
solid tumors,
dose escalation
Grants
(2)
A Phase 1/2, Open Label, Dose-Escalation Study Of Oral ORIN1001 With And Without Chemotherapy In The Treatment Of Subjects With Solid Tumors
Active
·
2022
·
$0 / $245.9K
·
External
oncology,
clinical trial,
chemotherapy,
solid tumors,
dose escalation
A Multicenter, Open-label, Phase 2 Study of Imprime PGG and Pembrolizumab in Patients with Metastatic Breast Cancer (mBCA) Who Have Progressed Through Prior Hormonal Therapy
Active
·
2022
·
$0 / $185.5K
·
External
cancer immunotherapy,
metastatic breast cancer,
immunotherapy combinations,
hormone therapy resistance
Collaborations
(7)
Fernanda Sanchez Borchardt
Mutual work: 2 Grants﹒4 Proposals
Collaboration Details
Carolyn Lane
Mutual work: 2 Grants﹒5 Proposals
Collaboration Details
Sylvia DeCero
Mutual work: 2 Grants﹒5 Proposals
Collaboration Details
Alaina Krone
Mutual work: 1 Supervisor
Collaboration Details
Cyndie Neal
Mutual work: 1 Supervisor
Collaboration Details
Page 1 of 2
Previous page
Next page
6+ Collaborators
$0 / $431.4K Funding
